Insulin Glargine - NDC Database
34 records found
Page:
0002-8214 Dec 16, 2015
Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company
Basaglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company
0002-8980 Dec 17, 2021
Rezvoglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company
Rezvoglar 100 [Iu]/Ml Subcutaneous Injection, Solution by Eli Lilly and Company
0024-5871 Feb 15, 2015
Toujeo Max 300 U/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
Toujeo Max 300 U/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
0088-2219 Sep 23, 2009
Lantus Solostar 100 [iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
Lantus Solostar 100 [iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
0088-2220 Sep 23, 2009
Lantus 100 [iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
Lantus 100 [iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
0088-5020 Jun 04, 2017
Lantus Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
Lantus Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
0088-5021 Jun 04, 2017
Lantus 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
Lantus 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
0955-1728 May 02, 2022
Insulin Glargine Solostar Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
Insulin Glargine Solostar Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
0955-1729 May 02, 2022
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
0955-2900 Jan 18, 2023
Insulin Glargine U-300 Max U-300 Max 300 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
Insulin Glargine U-300 Max U-300 Max 300 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
0955-3900 Jan 18, 2023
Insulin Glargine U-300 U-300 300 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
Insulin Glargine U-300 U-300 300 [Iu]/Ml Subcutaneous Injection, Solution by Winthrop U.S.
12854-432 May 02, 2022
Insulin Glargine Solostar Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis Deutschland Gmbh
Insulin Glargine Solostar Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis Deutschland Gmbh
12854-433 May 02, 2022
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis Deutschland Gmbh
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis Deutschland Gmbh
49502-393 Nov 16, 2021
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
49502-394 Nov 16, 2021
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
Insulin Glargine 100 [Iu]/Ml Subcutaneous Injection, Solution by Mylan Specialty L.p.
50090-0876 Sep 23, 2009
Lantus 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
Lantus 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
50090-1398 Sep 23, 2009
Lantus Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
Lantus Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
50090-4068 Sep 23, 2009
Lantus Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
Lantus Solostar 100 [Iu]/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
50090-4177 Feb 15, 2015
Toujeo Max 300 U/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
Toujeo Max 300 U/Ml Subcutaneous Injection, Solution by A-s Medication Solutions
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.